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Over the last decades, non-invasive myocardial perfusion imaging has shown major improvements and has consolidated its role as a mainstay for the workup of coronary artery disease. 1 While the most often applied technique for myocardial perfusion imaging is still single-photon emission tomography (SPECT) imaging, positron emission tomography (PET) for myocardial perfusion imaging has gained growing importance and acceptance in clinical routine. Reasons for that development are-besides the persisting intermittent shortage of Technetium-99m-technical advantages such as reliable tracer uptake quantification, higher count sensitivity, higher temporal and spatial resolution of PET. 2 Furthermore, PET myocardial perfusion imaging gets along with a substantially lower radiation exposure to the patient due to different physical properties of PET radiotracers such as shorter half-life. 3 Last not least, the probably most important advantage of PET myocardial perfusion imaging is the potential for absolute quantification of myocardial blood flow, a technique which has first been described in the 80s. 4 The superior extraction fraction of PET perfusion tracers compared to Technetium-99m-labeled SPECT agents and the calculation of absolute measures of myocardial blood flow also are main reasons for the superior diagnostic accuracy of PET over SPECT. [5] [6] [7] However, absolute quantification of myocardial blood flow is not trivial and there are many factors that may have major impact on the calculated results. 8 As indicated before, the different available PET perfusion tracers also have different physical (half-life, positron range etc. of the respective radionuclide) and biochemical [extraction/retention fraction, excretion mechanism, accumulation (e.g., N-13 ammonia, Rubidium-82) vs diffusion (O-15 water) etc.] properties, which all have to be taken into account. Also, the protocol needs to be designed carefully: for example, the generation of an accurate input function, which is calculated from a small region of interest (ROI) in the left atrium, left ventricular cavity, or the aorta when the radiotracer passes the heart may be incorrectly assessed if the radiotracer is injected too fast (i.e., with a too high activity concentration) which may drive the scanner into saturation. 9 The ROI location for the estimation of the input function per se may also have a substantial effect on blood flow results. 10 Obviously, motion and subsequent misalignment between PET and CT data may cause erroneous estimation of the myocardial blood flow. 11 It goes without saying that different scanners with different properties (crystal material, 2D vs. 3D scanners, timeof-flight availability etc.) may result in different estimations of myocardial blood flow. 12 Another important factor that may have substantial impact on myocardial blood flow estimation is the choice of kinetic model, which has to be picked carefully and in dependence of different factors, e.g., the applied perfusion tracer. 13 Another important factor (also on the post-processing side), which may have substantial effect on flow estimation, is the used software package. Different software packages implement different kinetic models, different corrections (e.g., spillover from blood to myocardium and vice versa) and require a different degree of user interaction. There are many software solutions for kinetic analysis of PET data in cardiac imaging on the Table 1 ). Most of these studies demonstrated a good to excellent agreement between the different software packages under the premise that the identical kinetic model was applied. For example, in one of the largest studies by Nesterov et al., a multicenter study comparing all existing software packages (N = 10) for the quantification of Rb-82 PET myocardial perfusion imaging, the authors concluded that when using the identical kinetic model, software solutions might be interchangeable.
14 While most such studies focused on the comparison of software packages in patients that were assessed for coronary artery disease in a daily clinical routine manner, the present manuscript focused on a certain subpopulation with structural changes of the left ventricular geometry, namely patients suffering from hypertrophic cardiomyopathy. This disease entity is the most common genetic cardiovascular disease in the general population and is therefore of daily importance in a cardiovascular imaging center. Patients with this disorder suffer from an increased left ventricular mass often with substantial hypertrophy of the septum, which is supplied by altered coronary arterioles and a reduced number of capillaries. It becomes obvious that these structural changes may result in erroneous segmentation of the left ventricular myocardial wall by the respective software and that also technical problems regarding e.g., partial volume and spillover correction may appear. Consequently, the authors of the present manuscript by Yalcin et al. found significant differences between the two tested software packages QPET and PMod in stress flow and coronary flow reserve values in patients with hypertrophic cardiomyopathy and high spillover fractions. The authors concluded that the anatomic characteristics in this patient population contribute to the differences found and that software packages may deliver substantial different myocardial blood flow values. Interestingly, the applied software 15 The absence or presence of motion correction is another factor which is crucial in the setting of scans which last for several minutes-especially in a post stress setting. This should all remind us that quantification software is not characterized by a single component-such as the choice of the particular kinetic model. The actual implementation is a rather multifactorial system, which might lead to differences between software packages based on the investigated patient cohort-a factor not commonly taken into consideration in studies comparing software.
Thus, the strength of this study is that it demonstrates that we have to act with high caution regarding myocardial blood flow quantification in patients with structural changes of the left ventricular wall and that further studies are warranted to elucidate the question what the best approach is to correctly quantify myocardial blood flow in such patient populations.
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